Churg-Strauss syndrome diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}; {{AE}}{{CK}}
{{CMG}}; {{AE}}{{CK}}
== Overview ==
== Overview ==
There are no specific diagnostic studies to confirm the diagnosis of [[eosinophilic granulomatosis with polyangiitis]], [[High Resolution CT|High resolution CT scan]] of lung and [[biopsy]] from various organs may be helpful in confirming the disease.


== Diagnostic Study of Choice ==
== Diagnostic Study of Choice ==
Line 15: Line 16:
*** Interlobular septal thickening
*** Interlobular septal thickening


*There are no established diagnostic tests to confirm the disease. However, bipsy may be considered for establishing diagnosis.
*Biopsy
**Biopsy
**Because of the multiple organ involvements, the biopsy should be obtained from any of the following organ sites:
***Because of the multiple organ involvements, the biopsy should be obtained from any of the following organ sites:
***Lung:
****Lung:
****The gold standard in establishing a diagnosis for eosinophilic granulomatosis with polyangiitis is a lung biopsy. surgical or transbronchial biopsy can be performed.
*****The gold standard in establishing a diagnosis for eosinophilic granulomatosis with polyangiitis is a lung biopsy. surgical or transbronchial biopsy can be performed.
***Skin
****Skin
***Nerve
****Nerve
***Kidney
****Kidney
***Muscle
****Muscle
**Biopsy findings may include eosinophilic infiltration, vasculitis of small and medium-sized vessels and granuloma formation.
***Biopsy findings may include eosinophilic infiltration, vasculitis of small and medium-sized vessels and granuloma formation.


=== Diagnostic Criteria ===
=== Diagnostic Criteria ===

Revision as of 20:41, 12 April 2018

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome diagnostic study of choice

CDC on Churg-Strauss syndrome diagnostic study of choice

Churg-Strauss syndrome diagnostic study of choice in the news

Blogs on Churg-Strauss syndrome diagnostic study of choice

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

There are no specific diagnostic studies to confirm the diagnosis of eosinophilic granulomatosis with polyangiitis, High resolution CT scan of lung and biopsy from various organs may be helpful in confirming the disease.

Diagnostic Study of Choice

  • High resolution CT scan:
    • High-resolution computerized tomography (HRCT) scan of patients with eosinophilic granulomatosis with polyangiitis will show the following findings:
      • Airspace consolidations mostly bilateral and lobular distribution
      • Ground-glass opacities, can be seen in a patchy or subpleural distribution, with inclination most commonly occurring in the lower zone portion of the lung
      • Centrilobular nodules
      • Bronchial wall thickening and/or dilatation
      • Pleural effusions
      • Hilar or mediastinal lymph node enlargement
      • Interlobular septal thickening
  • Biopsy
    • Because of the multiple organ involvements, the biopsy should be obtained from any of the following organ sites:
      • Lung:
        • The gold standard in establishing a diagnosis for eosinophilic granulomatosis with polyangiitis is a lung biopsy. surgical or transbronchial biopsy can be performed.
      • Skin
      • Nerve
      • Kidney
      • Muscle
    • Biopsy findings may include eosinophilic infiltration, vasculitis of small and medium-sized vessels and granuloma formation.

Diagnostic Criteria

According to the American College of Rheumatology classification criteria [1]

Asthma

Eosinophilia

Polyneuropathy or Mononeuropathy

Non fixed pulmonary infiltrates

Paranasal sinus that is abnormal

Eosinophils that are extravascular

Patients must express 4 out the 6 criteria to be diagnosed with eosinophilic granulomatosis with polyangiitis.

According to Lanham diagnostic criteria [2]

Asthma

Eosinophilia peak of >1.5x109 cell/L or >10% of the total WBC

Systemic vasculitis, two or greater extra pulmonary sites

All 3 criteria’s need to be present

References

  1. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP; et al. (1990). "The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)". Arthritis Rheum. 33 (8): 1094–100. PMID 2202307.
  2. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.

Template:WH Template:WS